Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

24 coronavirus projects for vaccines and therapeutics

FFG ad for Corona Research call © FFG

The Austrian Federal Government has now made an additional EUR 26 million available within the context of its “Corona Emergency Call".

The funds are designed to accelerate research being conducted to fight the coronavirus. 24 projects were selected in the first application round. Two of the 24 projects involve clinical studies on the development of vaccines, whereas eight projects focus on developing therapeutic agents. Twelve initiatives aim at developing diagnostic products, and two projects target infection prevention and control.

Vaccine development and development of therapeutics

The companies Themis Bioscience GmbH, Baxalta Innovations GmbH, Apeiron, AOP Orphan Pharmaceuticals AG, Cyprumed GmbH, Marinomed Biotech AG, Apeptico, Panoptes Pharma GesmbH and AIT Angewandte Informationstechnik operate in the field of "vaccine development".

Development of diagnostic products

The following firms focus on the "development of diagnostic products": Qualizyme Diagnostics, Attoquant Diagnostics GmbH, Viravaxx AG, Dr. Gernot Walder GmbH, Genspeed Biotech GmbH, Labdia Labordiagnostik, Lexogen GmbH, Next Generation Sequencing (NGS), Novogenia GmbH, Pharmgenetix GmbH, BioTreaT GmbH, SteadySense GmbH and RPD Rapid Product Development GmbH.

Find more details on the project (in German).

Read more about the current support for your company in times of Corona.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

Austria Map

Find the perfect location for your company
As a gaming machine and gaming software company, we particularly profit from the high level of education and innovative strength of Austria as a business location. We also value the strong loyalty and commitment of our local employees.

IGT Austria GmbH

igt
More testimonials

news from the business location Austria

Less gold is sometimes better

Using an ultra-thin gold layer, scientists at the Vienna University of Technology succeeded in creating an almost optimal infrared absorber.

Silicon Austria Labs: Top Research Centre in the Field of EBS

Since 2018, Silicon Austria Labs (SAL) has been enriching the European EBS ecosystem (EBS=Electronic Based Systems). The special feature of this research centre is that it conducts international oriented, multidisciplinary and collaborative research along the entire EBS value chain, from sensors to integrated systems.

More news All blog posts